OPKO HEALTH INC.

Inactive Instrument

Analyst Reco. Opko Health Inc. Nyse

Equities

OPK

US68375N1037

Real-time Estimate Cboe BZX Other stock markets 07:45:10 02/07/2024 pm IST			5-day change	1st Jan Change
1.215 ^USD	0.00%		0.00%	0.00%

07/05	Earnings Flash (OPK) OPKO HEALTH Posts Q1 Revenue $173.7M, vs. Street Est of $183M	MT
07/05	Opko Health, Inc. Provides Earnings Guidance for the Second Quarter of 2024	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Barrington Cuts Price Target on OPKO Health to $1.50 From $2, Maintains Outperform Rating	28/02	MT
Barrington Upgrades OPKO Health to Outperform From Market Perform, Price Target is $2	29/23/29	MT
HC Wainwright Initiates Coverage on OPKO Health With Buy Rating, $3 Price Target	15/22/15	MT
Piper Sandler Adjusts OPKO Health's Price Target to $4 From $5, Reiterates Overweight Rating	05/22/05	MT
Piper Sandler Adjusts OPKO Health's Price Target to $5 From $6, Reiterates Overweight Rating	10/22/10	MT
Barrington Research Downgrades Opko Health Inc to Market Perform From Outperform	24/22/24	MT
OPKO HEALTH : Barrington Adjusts Price Target on Opko Health to $6 From $8 on Lab Unit Revenue Decline, Maintains Outperform Rating	30/21/30	MT
OPKO HEALTH : Ladenburg Thalmann Starts Opko Health at Buy With $7 Price Target	21/21/21	MT
OPKO Health, Inc. Reports Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2018; Provides Revenue Guidance for Third Quarter of 2018; Reaffirms Tax Rate Guidance for the Full Year 2018	08/18/08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer